BioInnovation Institute (BII) has committed €8 million to six companies focusing on health and sustainability. This financial commitment reflects BII's continued support for innovative technological advancements in the life sciences and climate tech sectors.
Each of the six companies—PanTarg, 3Sonic, Inia Biosciences, Yngvi Bio, Proxi Biotech, and Sagava—will receive €1.3 million, bringing BII's total investment in each to €1.8 million. This funding is structured as convertible loans to support their growth and commercialization efforts.
This strategic financial allocation underscores the importance of investment in fostering advancements in critical sectors, enhancing BII's reputation as a key player in the biotech and climate tech arenas.
